Preventing infections in blood cancer patients with low white cells
Part of Blood & lymphatic, Cancer clinical trials.
This Phase 2 study tests whether taking Xerava (an antibiotic) can prevent serious infections in people who have prolonged low neutrophils after chemotherapy or transplant preparation. If it works, it may lower the risk of infections during the highest-risk period after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are starting treatment for acute leukemia, or getting ready for a stem cell transplant (HSCT)
- You can give informed consent (or your legal guardian can)
- Your liver blood tests are not too high: bilirubin is within 3 times normal, and AST/ALT are within 5 times normal
- You do not have an uncontrolled ongoing infection (bacterial, viral, or fungal) when you start
- You are not being actively treated for a current urine infection (UTI)
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood cancer patients who are carrying a certain type of antibiotic-resistant bacteria (without causing infection yet). It aims to develop a score to predict which patients might later develop an infection. If you are receiving treatment that lowers your white blood cells (neutropenia), you may be eligible.
This trial tests if mavorixafor can help people with certain types of long-term low neutrophil counts (chronic neutropenia) who still get frequent or serious infections. It aims to reduce infection risk by boosting your body's infection-fighting cells.
This study tests the best time to start powerful antibiotics in blood cancer patients who are at high risk for infection with carbapenem-resistant bacteria. It aims to improve treatment success and reduce complications.
This study looks at how the drug eravacycline works in the body of critically ill patients whose first antibiotic didn't work. It aims to find the best dose to fight the infection.
This trial tests whether giving antibiotics to prevent infections helps patients with myelodysplastic syndromes or acute myeloid leukemia who are starting a specific type of chemotherapy called hypomethylating agents. Preventing infections could help patients stay healthier during treatment.
This trial tests whether adding eravacycline to standard treatment can help clear a tough lung infection caused by bacteria that don't respond to many antibiotics. It's for adults with pneumonia who have already started eravacycline.
Hear when a new Neutropenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.